Cardinal Health, Inc. last reported quarterly results on Aug 11, 2026, for Q4 FY2026 (the quarter ended Jun 30, 2026): revenue of $63.7 billion (+5.8% year over year). It usually reports 30–42 days after a quarter ends. Based on that pattern, the next release is estimated for around Oct 29, 2026.
Results for Q1 FY2027, the quarter ending around Sep 30, 2026. Expected on a Thursday. Based on last year's release for the same quarter on Oct 30, 2025. The company has not filed these results with the SEC yet. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 30–42 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 11, 2026
42 days after quarter end
From press release
|
Q4 FY2026
ended Jun 30, 2026
|
63,672
+5.8%
|
—
|
—
|
|
Apr 30, 2026
30 days after quarter end
From press release
|
Q3 FY2026
ended Mar 31, 2026
|
60,940
+11.0%
|
399
-21.1%
|
1.69
-19.5%
|
|
Feb 5, 2026
36 days after quarter end
|
Q2 FY2026
ended Dec 31, 2025
|
65,627
+18.8%
|
467
+16.8%
|
1.97
+19.7%
|
|
Oct 30, 2025
30 days after quarter end
|
Q1 FY2026
ended Sep 30, 2025
|
64,009
+22.4%
|
450
+8.2%
|
1.88
+10.6%
|
|
Aug 12, 2025
43 days after quarter end
|
Q4 FY2025
ended Jun 30, 2025
|
60,159
+0.5%
|
239
+1.7%
|
1.00
+5.1%
|
|
May 1, 2025
31 days after quarter end
|
Q3 FY2025
ended Mar 31, 2025
|
54,878
+0.0%
|
506
+93.9%
|
2.10
+97.1%
|
|
Jan 30, 2025
30 days after quarter end
|
Q2 FY2025
ended Dec 31, 2024
|
55,264
-3.8%
|
400
+8.7%
|
1.65
+10.0%
|
|
Nov 1, 2024
32 days after quarter end
|
Q1 FY2025
ended Sep 30, 2024
|
52,277
-4.3%
|
416
+3566.7%
|
1.70
+3500.0%
|
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- CAH (NYSE)
- Fiscal year ends
- June 30
- Incorporated in
- OH
- Headquarters
- Dublin, OH
- SEC filer status
- Large accelerated filer
- SEC CIK
- 721371
- Former names
- CARDINAL HEALTH INC (until Oct 1, 2026); CARDINAL DISTRIBUTION INC (until Feb 17, 1994)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cencora, Inc. COR
- Herbalife Ltd. HLF
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- DataMeds AI, Inc. MEDS
- Cellyan Biotechnology Co., Ltd HKPD
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.